Parikh U - Search Results

1

Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study.

Hensley MK, Bain WG, Jacobs J, Nambulli S, Parikh U, Cillo A, Staines B, Heaps A, Sobolewski MD, Rennick LJ, Macatangay BJC, Klamar-Blain C, Kitsios GD, Methé B, Somasundaram A, Bruno TC, Cardello C, Shan F, Workman C, Ray P, Ray A, Lee J, Sethi R, Schwarzmann WE, Ladinsky MS, Bjorkman PJ, Vignali DA, Duprex WP, Agha ME, Mellors JW, McCormick KD, Morris A, Haidar G. Hensley MK, et al. Among authors: parikh u. Clin Infect Dis. 2021 Aug 2;73(3):e815-e821. doi: 10.1093/cid/ciab072. Clin Infect Dis. 2021. PMID: 33507235 Free PMC article.

2

Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trial.

Nair G, Celum C, Szydlo D, Brown ER, Akello CA, Nakalega R, Macdonald P, Milan G, Palanee-Phillips T, Reddy K, Tahuringana E, Muhlanga F, Nakabiito C, Bekker LG, Siziba B, Hillier SL, Baeten JM, Garcia M, Johnson S, McClure T, Levy L, Livant E, Jacobson C, Soto-Torres L, van der Straten A, Hosek S, Rooney JF, Steytler J, Bunge K, Parikh U, Hendrix C, Anderson P, Ngure K; REACH Protocol Team. Nair G, et al. Among authors: parikh u. Lancet HIV. 2023 Dec;10(12):e779-e789. doi: 10.1016/S2352-3018(23)00227-8. Epub 2023 Oct 25. Lancet HIV. 2023. PMID: 37898146 Free PMC article. Clinical Trial.

3

ALIGNMENT OF PREP USE WITH POTENTIAL HIV EXPOSURE IN YOUNG WOMEN AND MEN IN UGANDA.

Wu L, Ssebuliba T, Muwonge TR, Bambia F, Stein G, Nampewo O, Sapiri O, Goetz BJ, Penrose KJ, Parikh UM, Mujugira A, Heffron R. Wu L, et al. Among authors: parikh um. J Acquir Immune Defic Syndr. 2024 Dec 4. doi: 10.1097/QAI.0000000000003573. Online ahead of print. J Acquir Immune Defic Syndr. 2024. PMID: 39630076

4

In vitro activity of structurally diverse nucleoside analogs against human immunodeficiency virus type 1 with the K65R mutation in reverse transcriptase.

Parikh UM, Koontz DL, Chu CK, Schinazi RF, Mellors JW. Parikh UM, et al. Antimicrob Agents Chemother. 2005 Mar;49(3):1139-44. doi: 10.1128/AAC.49.3.1139-1144.2005. Antimicrob Agents Chemother. 2005. PMID: 15728915 Free PMC article.

5

The 3'-azido group is not the primary determinant of 3'-azido-3'-deoxythymidine (AZT) responsible for the excision phenotype of AZT-resistant HIV-1.

Sluis-Cremer N, Arion D, Parikh U, Koontz D, Schinazi RF, Mellors JW, Parniak MA. Sluis-Cremer N, et al. Among authors: parikh u. J Biol Chem. 2005 Aug 12;280(32):29047-52. doi: 10.1074/jbc.M503166200. Epub 2005 Jun 20. J Biol Chem. 2005. PMID: 15970587 Free article.

6

In vitro selection and analysis of human immunodeficiency virus type 1 resistant to derivatives of beta-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine.

Hammond JL, Parikh UM, Koontz DL, Schlueter-Wirtz S, Chu CK, Bazmi HZ, Schinazi RF, Mellors JW. Hammond JL, et al. Antimicrob Agents Chemother. 2005 Sep;49(9):3930-2. doi: 10.1128/AAC.49.9.3930-3932.2005. Antimicrob Agents Chemother. 2005. PMID: 16127074 Free PMC article.

7

The K65R mutation in human immunodeficiency virus type 1 reverse transcriptase exhibits bidirectional phenotypic antagonism with thymidine analog mutations.

Parikh UM, Bacheler L, Koontz D, Mellors JW. Parikh UM, et al. J Virol. 2006 May;80(10):4971-7. doi: 10.1128/JVI.80.10.4971-4977.2006. J Virol. 2006. PMID: 16641288 Free PMC article.

8

Antagonism between the HIV-1 reverse-transcriptase mutation K65R and thymidine-analogue mutations at the genomic level.

Parikh UM, Barnas DC, Faruki H, Mellors JW. Parikh UM, et al. J Infect Dis. 2006 Sep 1;194(5):651-60. doi: 10.1086/505711. Epub 2006 Jul 24. J Infect Dis. 2006. PMID: 16897664

9

Molecular mechanism by which the K70E mutation in human immunodeficiency virus type 1 reverse transcriptase confers resistance to nucleoside reverse transcriptase inhibitors.

Sluis-Cremer N, Sheen CW, Zelina S, Torres PS, Parikh UM, Mellors JW. Sluis-Cremer N, et al. Antimicrob Agents Chemother. 2007 Jan;51(1):48-53. doi: 10.1128/AAC.00683-06. Epub 2006 Nov 6. Antimicrob Agents Chemother. 2007. PMID: 17088490 Free PMC article.

10

Molecular mechanisms of bidirectional antagonism between K65R and thymidine analog mutations in HIV-1 reverse transcriptase.

Parikh UM, Zelina S, Sluis-Cremer N, Mellors JW. Parikh UM, et al. AIDS. 2007 Jul 11;21(11):1405-14. doi: 10.1097/QAD.0b013e3281ac229b. AIDS. 2007. PMID: 17589186

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters